|
MSH2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.764400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.202000E-02 |
| Normal-vs-Stage2 |
1.657500E-02 |
| Normal-vs-Stage3 |
6.524400E-03 |
| Normal-vs-Stage4 |
2.997100E-03 |
| Stage1-vs-Stage2 |
1.450000E-01 |
| Stage1-vs-Stage3 |
1.520550E-01 |
| Stage1-vs-Stage4 |
6.605700E-02 |
| Stage2-vs-Stage3 |
6.982000E-01 |
| Stage2-vs-Stage4 |
9.844200E-01 |
| Stage3-vs-Stage4 |
6.796200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.584800E-03 |
| Normal-vs-AfricanAmerican |
9.284200E-01 |
| Normal-vs-Asian |
2.921000E-01 |
| Caucasian-vs-AfricanAmerican |
1.636790E-01 |
| Caucasian-vs-Asian |
3.614200E-01 |
| AfricanAmerican-vs-Asian |
5.411800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.679900E-03 |
| Normal-vs-Female |
2.537500E-02 |
| Male-vs-Female |
2.500600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.507630E-01 |
| Normal-vs-Age(41-60Yrs) |
1.848100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.820400E-03 |
| Normal-vs-Age(81-100Yrs) |
6.530200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.992600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.004000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.674400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.018400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.666400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.454800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.793000E-01 |
| Classical-VS-Follicular |
1.73606999999132E-05 |
| Classical-VS-Other |
1.995800E-01 |
| Classical-VS-Normal |
3.441000E-01 |
| Tall-VS-Follicular |
6.760100E-02 |
| Tall-VS-Other |
4.246600E-01 |
| Tall-VS-Normal |
6.604100E-02 |
| Follicular-VS-Other |
8.562600E-01 |
| Follicular-VS-Normal |
4.39720000000587E-05 |
| Other-VS-Normal |
6.195800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.722600E-03 |
| Normal-vs-N1 |
1.301590E-03 |
| N0-vs-N1 |
3.304800E-01 |
|
|
